Arvelle Therapeutics International GmbH
a company of Angelini Pharma Group
6301 – Zug (Switzerland)
Angelini Pharma Headquarters
Viale Amelia, 70
00181 – Rome (Italy)
For health-related issues, we encourage you to contact your doctor or health care provider.
For the notification to Arvelle/Angelini of undesirable side effects, product complaints and medical information enquiries, please use a contact detail reported below: